Allergy/Imm Medical News about asthma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma
Annals of Allergy, Asthma, and Immunology, 10/15/09

Van Dalen CJ et al. – 3–Bromotyrosine and 3,5–dibromotyrosine levels reflect treatment effects in asthma and support previous findings that SABAs impair the anti–inflammatory effects of inhaled corticosteroids. In addition to eosinophil numbers and eosinophil cationic protein levels, these modified tyrosine residues provide useful information about the inflammatory state of the airways.

<< Previous
Social protection to support vulnerable children and families:...

Next >>
High sensitization rate to food allergens in breastfed infants...